SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.【JP:2395】Dividends
Market cap
¥64.4B
P/E ratio
18.1x
Provides drug development testing services to pharmaceutical companies and operates innovative intranasal drug delivery technology through spinout companies.
Latest Dividend per Share Forecast
50.00JPY
If you buy 100 shares of SHIN NIPPON BIOMEDICAL LABORATORIES, LTD., the expected annual dividend is 5,000 JPY.
- Dividend Yield
- 3.2%
- Payout Ratio
- 58.6%
Dividend Policy
<p>The Company regards stable profit dividends to shareholders as one of its key policies. The basic policy is to decide on dividends by taking into account fundamental earnings capacity, cash flow conditions, and other factors, with a consolidated payout ratio target of 30–40%. Dividends from retained earnings are paid twice annually as a general rule: an interim dividend and a year-end dividend. Retained earnings are reserved to strengthen the Company's financial position and prepare for future business expansion.</p>
Dividend per Share
Payout Ratio
Dividend Yield
Dividend History (Forecasts, Revisions, Actuals)
| Fiscal Year | Type | Interim | Year-End | Total | Payout Ratio |
| FY2026 | Forecast(2025/05/08) | 20 | 30 | 50 | 58.6% |
|---|---|---|---|---|---|
| FY2025 | Actual(2025/05/08) | 20 | 30 | 50 | 42.3% |
| Forecast(2024/05/08) | 20 | 30 | 50 | 53.3% | |
| FY2024 | Actual(2024/05/08) | 20 | 30 | 50 | 37.6% |
| Forecast(2023/05/08) | 20 | 30 | 50 | 46.2% | |
| FY2023 | Actual(2023/05/08) | 20 | 30 | 50 | 34.3% |
| Revision(2023/01/31) | 20 | 30 | 50 | - | |
| Forecast(2022/05/06) | 20 | 20 | 40 | 38.7% | |
| FY2022 | Actual(2022/05/06) | 0 | 40 | 40 | 23.4% |
| Revision(2021/08/04) | 0 | 20 | 20 | - | |
| Forecast(2021/05/10) | - | 20 | 20 | 21.3% | |
| FY2021 | Actual(2021/05/10) | 0 | 20 | 20 | 22.7% |
| Forecast(2020/11/06) | 0 | 5 | 5 | - | |
| FY2020 | Actual(2020/11/06) | 0 | 5 | 5 | - |